Benjamin Weinberg News Today

Georgetown University researchers have begun a clinical trial for a new pancreatic cancer treatment that they found successful in mice, the Georgetown University Hospital announced Feb. 2. Dr. Louis Weiner, a professor of oncology and the director of the MedStar Georgetown University Lombardi Comprehensive Cancer Center, led a study that laid the groundwork for the...

Georgetown University researchers have begun a clinical trial for a new pancreatic cancer treatment that they found successful in mice, the Georgetown University Hospital announced Feb. 2. Dr. Louis Weiner, a professor of oncology and the director of the MedStar Georgetown University Lombardi Comprehensive Cancer Center, led a study that laid the groundwork for the...

Researchers have found a possible reason as to why rates of colorectal cancer cases have spiked among patients under 50.

FRIDAY, May 26, 2023 (HealthDay News) -- With colon cancer on the rise among younger Americans, researchers are working to figure out why.

With colon cancer on the rise among younger Americans, researchers are working to figure out why.

Doctors at Georgetown University in Washington D.C. say that changes to the microbiome and a fungus in the tumors of young patients could be behind a higher risk of developing colon cancer.

Eileen O’Reilly, MD, and Benjamin Weinberg, MD, discuss the importance of conducting biomarker testing as the gastrointestinal cancer treatment arena continues to evolve, the need for increased gene fusion testing, and the negative effects of inadequate biomarker testing in the gastrointestinal cancer population.

My namesake aunt died in her 30s from colorectal cancer, a once rare occurrence. Now people in their 20s, 30s, and 40s are getting this disease, so I asked experts why this is happening — and what people like me can do about it.

My namesake aunt died in her 30s from colorectal cancer, a once rare occurrence. Now people in their 20s, 30s, and 40s are getting this disease, so I asked experts why this is happening — and what people like me can do about it.

Testing for molecular residual disease was able to identify patients with early-stage colorectal cancer who are most likely to benefit from adjuvant chemotherapy.